Clinical Trial Update: Y-3 for Injection in the Treatment of Acute Ischemic Stroke [Phase 3]

View source ↗

Summary

Phase 3 clinical trial recruiting for Y-3 for Injection to treat acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Y-3 for Injection

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Acute Ischemic Stroke | Phase 3 | Status: RECRUITING